ConductScience.org, home

Paper628199

[Drug treatment of primary hyperlipoproteinemia (author's transl)].

Klose G and 4 others. Klin Wochenschr, 1978. Cited by 13 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. [Drug treatment of primary hyperlipoproteinemia (author's transl)]. Papers, record 628199. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/628199

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
[Drug treatment of primary hyperlipoproteinemia (author's transl)].
PubMed
Journal
Klin Wochenschr
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
0.75
iCite
Revised in PubMed
2020-03-04
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Klose GG
2Mordasini RR
3Middelhoff GG
4Augustin JJ
5Greten HH

Source PubMed

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HyperlipidemiasMajor topic
Anion Exchange Resins
Biguanides
Cholestyramine Resin
Clofibrate
Colestipol
DEAE-Dextran
Dextrothyroxine
Drug Therapy, Combination
Estrogens
Humans
Lipoproteins
Neomycin
Nicotinic Acids
Progestins
Sitosterols

Source PubMed

References112

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
15,679,950Effect of nicotinic acid on plasma lipids in patients with hyperlipoproteinemia during the first week of treatment.J Atheroscler Res1968https://conductscience.org/library/papers/5679950PubMed
25,652,004Effect of nicotinic acid on catabolism and synthesis of cholesterol in man.Clin Chim Acta1968https://conductscience.org/library/papers/5652004PubMed
3188,431Binding to plasma lipoproteins of chlorophenoxyisobutyric, tibric and nicotinic acids and their esters: its significance for the mechanism of lipid lowering by clofibrate and related drugs.Atherosclerosis1976https://conductscience.org/library/papers/188431PubMed
45,994,695[Treatment of hypercholesteremia with beta-pyridylcarbinol. I. Biochemistry and clinical results].Med Klin1966https://conductscience.org/library/papers/5994695PubMed
54,357,927[Treatment of primary hyperlipoproteinaemia types, IIa, IIb, 3 and IV with clofibrate (author's transl)].Dtsch Med Wochenschr1973https://conductscience.org/library/papers/4357927PubMed
64,126,562Portacaval shunt in hyperlipoproteinaemia.Lancet1973https://conductscience.org/library/papers/4126562PubMed
713,730,812Reductuon of serum-cholesterol by dextro-thyroxine in men with coronary heart-disease.Lancet1961https://conductscience.org/library/papers/13730812PubMed
84,562,098Colestipol and cholestyramine resin. Comparative effects in familial type II hyperlipoproteinemia.JAMA1972https://conductscience.org/library/papers/4562098PubMed
104,746,523Effects and side-effects of treatment of hypercholesterolemia with cholestyramine and neomycin.Acta Med Scand1973https://conductscience.org/library/papers/4746523PubMed
115,570,460Regulation of hepatic cholesterol biosynthesis by clofibrate administration.J Pharmacol Exp Ther1971https://conductscience.org/library/papers/5570460PubMed
125,470,476Precipitation by neomycin compounds of fatty acid and cholesterol from mixed micellar solutions.Eur J Clin Invest1970https://conductscience.org/library/papers/5470476PubMed
131,001,205[Combination of clofibrate and phenformin in the treatment of endogenous hypertriglyceridaemia (author's transl)].Dtsch Med Wochenschr1976https://conductscience.org/library/papers/1001205PubMed
145,764,121Measurements of cholesterol turnover, synthesis, and absorption in man, carried out by isotope kinetic and sterol balance methods.J Lipid Res1969https://conductscience.org/library/papers/5764121PubMed
15971,343Treatment of hypercholesterolemia with Secholex. A long-term clinical trial and comparison with cholestyramine.Atherosclerosis1976https://conductscience.org/library/papers/971343PubMed
1675,786[Mechanism of action of synthetic heparinoids: results in patients with hypertriglyceridaemia (author's transl)].Dtsch Med Wochenschr1978https://conductscience.org/library/papers/75786PubMed
175,831,724Chemotherapy of hyperlipidemia.Mayo Clin Proc1965https://conductscience.org/library/papers/5831724PubMed
185,420,622Reduction of serum cholesterol and triglyceride levels by the combined administration of neomycin and clofibrate.Circulation1970https://conductscience.org/library/papers/5420622PubMed
194,982,663Hypolipidemic agents.Prog Drug Res1969https://conductscience.org/library/papers/4982663PubMed
201,101,545[Clinical testing of a combination of clofibrate and beta-pyridylcarbinol in an unusual dosis relation].Z Allgemeinmed1975https://conductscience.org/library/papers/1101545PubMed
215,433,090Effects of colestipol (U-26,597A), a new bile acid sequestrant, on serum lipids in experimental animals and man.Atherosclerosis1970https://conductscience.org/library/papers/5433090PubMed

See all 112 references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn Papers
6,876,687[Relation between serum lipoprotein metabolism and biliary lipid metabolism].Klin Wochenschr1983https://conductscience.org/library/papers/6876687

Source PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/628199

GET https://conductscience.org/api/papers/v1/628199/references?page=2